Prevalence of Migraine and Other Headaches in Hong KongWong T.W.a · Wong K.S.b · Yu T.S.a · Kay R.b
a Department of Community and Family Medicine and b Department of Medicine, The Chinese University of Hong Kong, Hong Kong
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
From July 1992 to March 1993, we conducted a community-based prevalence survey of migraine and other types of recurrent headache by a telephone interview of 2,240 households with 7,356 persons aged 15 and above. 311 patients with recurrent headache were successfully interviewed. Of these, 101 were clinically validated. The overall prevalence rates were 1% for migraine, 2% for tension-type headache and 1% for unclassified headache. Adjusted for misclassification and non-response, the estimated prevalence rates for the three categories were 1.5, 3 and 0.4%, respectively. Agreement between clinical method and questionnaire interview was good for migraine, fair for tension-type headache and poor for unclassified headache. For all three types of recurrent headache, there was a female preponderance with a peak in the 25–44 age group. The prevalence of migraine was much lower than in Western communities but higher than that found in mainland China [1–8]. Common predisposing and aggravating factors for all three types of headaches as reported by the patients were mental stress, physical exertion and menstruation among females. Despite the low prevalence, the overall socioeconomic impact to a populous community is considerable.
© 1995 S. Karger AG, Basel
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.